Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535610-15-000054
Filing Date
2015-04-02
Accepted
2015-04-02 14:28:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G XTLB 4.02.15 xtlb0415.txt SC 13G 13579
  Complete submission text file 0001535610-15-000054.txt   15114
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Subject) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-83127 | Film No.: 15746806
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G